首页> 美国卫生研究院文献>Asia Oceania Journal of Nuclear Medicine and Biology >Evaluation of 99m Tc-MccJ25 peptide analog in mice bearing B16F10 melanoma tumor as a diagnostic radiotracer
【2h】

Evaluation of 99m Tc-MccJ25 peptide analog in mice bearing B16F10 melanoma tumor as a diagnostic radiotracer

机译:评价带有B16F10黑色素瘤肿瘤的99m Tc-MccJ25肽类似物作为放射性示踪剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective(s):Despite recent advances in treatment modalities, cancer remains a major source of morbidity and mortality throughout the world. Currently, the development of sensitive and specific molecular imaging probes for early diagnosis of cancer is still a problematic challenge. Previous studies have been shown that some of the antimicrobial peptides (AMPs) exhibit a broad spectrum of cytotoxic activity against cancerous cells in addition to their antimicrobial activities. MicrocinJ25 (MccJ25) is an antimicrobial peptide that is produced by Escherichia coli (E. coli) strain. The aim of this study was to investigate the potential of a new peptide radiopharmaceutical derived from MccJ25 for diagnosis of melanoma tumor bearing C57BL/6 mice.
机译:目标:尽管治疗方法最近取得进展,但癌症仍然是全世界发病率和死亡率的主要来源。当前,用于癌症的早期诊断的灵敏和特异性分子成像探针的开发仍然是有问题的挑战。先前的研究表明,某些抗微生物肽(AMPs)除具有抗微生物活性外,还具有针对癌细胞的广泛细胞毒性活性。 MicrocinJ25(MccJ25)是一种由大肠杆菌(E. coli)菌株产生的抗菌肽。这项研究的目的是研究一种新的源自MccJ25的肽放射药物在诊断C57BL / 6小鼠黑色素瘤中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号